Insulin-like growth factor I: could it be a marker of prematurity in the foal?

S Panzani1, C Castagnetti, A Prandi

  • 1Department of Health, Animal Science and Food Safety, Faculty of Veterinary Medicine, Università degli Studi di Milano, Milan, Italy.

Theriogenology
|December 11, 2012
PubMed

Insights

Insulin-like growth factor I (IGF-I) levels rise in healthy foals after birth, but prematurity only partially affects these levels. IGF-I is not a reliable diagnostic marker for prematurity in newborn foals.

Area of Science:

  • Veterinary Medicine
  • Neonatology
  • Endocrinology

Background:

  • Insulin-like growth factor I (IGF-I) is a crucial regulator of fetal and neonatal growth.
  • Plasma IGF-I levels are dynamic post-birth and influenced by factors like sex, age, nutrition, and prematurity.

Purpose of the Study:

  • Evaluate the IGF-I plasma profile in healthy newborn foals during the first two weeks of life.
  • Assess the influence of sex, birth weight, and prematurity on IGF-I levels.
  • Determine if IGF-I can serve as a diagnostic marker for prematurity in foals.

Main Methods:

  • Plasma samples collected from 34 healthy term foals and 11 premature foals at various time points.
  • Insulin-like growth factor I (IGF-I) concentrations analyzed using radioimmunoassay (RIA).
  • Statistical analysis to compare IGF-I levels between groups and over time.

Main Results:

  • Healthy foals showed an increasing trend in IGF-I concentrations from Day 4 to 10.
  • No significant differences in IGF-I levels were found related to sex or birth weight in healthy foals.
  • Premature foals exhibited an increasing trend but without statistical differences among sampling times; IGF-I was not a reliable diagnostic marker for prematurity.

Conclusions:

  • Prematurity appears to only partially affect IGF-I plasma concentrations in newborn foals.
  • IGF-I is not a reliable diagnostic marker for identifying prematurity in foals.
  • Further research may be needed to understand the complex interplay of factors influencing IGF-I in neonatal equine health.

Related Concept Videos